We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Effect of Low-Dose Celecoxib on SMN2 in Patients With Spinal Muscular Atrophy (SMA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02876094
Recruitment Status : Terminated (Terminated: Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention)
First Posted : August 23, 2016
Last Update Posted : October 19, 2020
Families of Spinal Muscular Atrophy
Gwendolyn Strong Foundation
Information provided by (Responsible Party):
Hugh McMillan, Children's Hospital of Eastern Ontario

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : August 6, 2020
Actual Study Completion Date : August 6, 2020